The efficacy and tolerability of pericyazine in the treatment of patients with schizotypal disorder, organic personality disorders and...
Данилов Д. С.
Журнал неврологии и психиатрии им. C.C. Корсакова
Т. 117, Вып. 10, С. 65-71
Опубликовано: 2017
Тип ресурса: Статья
DOI:10.17116/jnevro201711710165-71
Аннотация:
Objective. To assess the efficacy and tolerability of pericyazine in the treatment of patients with mental disorders manifesting with psychopathic-like symptoms and correction of pathocharacterological disorders in patients with personality disorders during the short-term admission to the hospital or the long-term outpatient treatment. Material and methods. Sixty-three patients with schizotypal personality disorder and organic personality disorder with psychopathic-like symptoms and pathocharacterological changes within the diagnosis of dissocial personality disorder and borderline personality disorder were examined. Patients received pericyazine during the short-term admission to the hospital (6 weeks) or the long-term outpatient treatment (6 month). Efficacy, tolerability and compliance were assessed in the study. Results and conclusion. Treatment with pricyazine was effective in all patients. The improvement was seen in patients with organic personality disorders and patients with p
Ключевые слова:
Compliance; Dissocial disorder; Efficacy; Impulsive type of emotional unstable personality disorder; Pathocharacterological disorders; Pericyazine; Personality disorder; Psychopathic-like symptoms; Schizotypal disorder; Tolerability
periciazine; periciazine; phenothiazine derivative; Article; borderline state; drug efficacy; drug tolerability; extrapyramidal symptom; hospital patient; human; impulsiveness; major clinical study; metabolic syndrome X; organic personality disorder; organic personality disorder; outpatient care; personality disorder; psychopathy; schizotypal personality disorder; adolescent; adult; ambulatory care; antisocial personality disorder; borderline state; female; hospital admission; male; middle aged; outpatient; psychosis; schizotypal personality disorder; treatment outcome; young adult; Adolescent; Adult; Ambulatory Care; Antisocial Personality Disorder; Borderline Personality Disorder; Female; Humans; Inpatients; Male; Middle Aged; Outpatients; Patient Admission; Phenothiazines; Psychotic Disorders; Schizotypal Personality Disorder; Treatment Outcome; Young Adult
Язык текста: Русский
ISSN: 2309-4729
Данилов Д. С.
Danilov D. S.
The efficacy and tolerability of pericyazine in the treatment of patients with schizotypal disorder, organic personality disorders and pathocharacterological changes within personality disorders
The efficacy and tolerability of pericyazine in the treatment of patients with schizotypal disorder, organic personality disorders and...
Текст визуальный непосредственный
Журнал неврологии и психиатрии им. C.C. Корсакова
Издательство Медиа Сфера
Т. 117, Вып. 10 С. 65-71
2017
Статья
Compliance Dissocial disorder Efficacy Impulsive type of emotional unstable personality disorder Pathocharacterological disorders Pericyazine Personality disorder Psychopathic-like symptoms Schizotypal disorder Tolerability
periciazine periciazine phenothiazine derivative Article borderline state drug efficacy drug tolerability extrapyramidal symptom hospital patient human impulsiveness major clinical study metabolic syndrome X organic personality disorder organic personality disorder outpatient care personality disorder psychopathy schizotypal personality disorder adolescent adult ambulatory care antisocial personality disorder borderline state female hospital admission male middle aged outpatient psychosis schizotypal personality disorder treatment outcome young adult Adolescent Adult Ambulatory Care Antisocial Personality Disorder Borderline Personality Disorder Female Humans Inpatients Male Middle Aged Outpatients Patient Admission Phenothiazines Psychotic Disorders Schizotypal Personality Disorder Treatment Outcome Young Adult
Objective. To assess the efficacy and tolerability of pericyazine in the treatment of patients with mental disorders manifesting with psychopathic-like symptoms and correction of pathocharacterological disorders in patients with personality disorders during the short-term admission to the hospital or the long-term outpatient treatment. Material and methods. Sixty-three patients with schizotypal personality disorder and organic personality disorder with psychopathic-like symptoms and pathocharacterological changes within the diagnosis of dissocial personality disorder and borderline personality disorder were examined. Patients received pericyazine during the short-term admission to the hospital (6 weeks) or the long-term outpatient treatment (6 month). Efficacy, tolerability and compliance were assessed in the study. Results and conclusion. Treatment with pricyazine was effective in all patients. The improvement was seen in patients with organic personality disorders and patients with p